Chemoinformaics analysis of Furanoeudesma-1,3-diene
| Molecular Weight | 214.308 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 15 |
| Exact Molecular Weight | 214.136 | nRing | 3 |
| Solubility: LogS | -3.651 | nHRing | 1 |
| Solubility: LogP | 4.262 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
| nHA | 1 | APOL | 37.8543 |
| nHD | 0 | BPOL | 19.7937 |
| QED | 0.639 |
| Synth | 4.354 |
| Natural Product Likeliness | 3.05 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.374 |
| Pgp-sub | 0.026 |
| HIA | 0.003 |
| CACO-2 | -4.832 |
| MDCK | 0.0000378 |
| BBB | 0.087 |
| PPB | 0.956791 |
| VDSS | 3.13 |
| FU | 0.0458561 |
| CYP1A2-inh | 0.726 |
| CYP1A2-sub | 0.262 |
| CYP2c19-inh | 0.441 |
| CYP2c19-sub | 0.791 |
| CYP2c9-inh | 0.319 |
| CYP2c9-sub | 0.082 |
| CYP2d6-inh | 0.917 |
| CYP2d6-sub | 0.676 |
| CYP3a4-inh | 0.773 |
| CYP3a4-sub | 0.485 |
| CL | 11.809 |
| T12 | 0.423 |
| hERG | 0.372 |
| Ames | 0.011 |
| ROA | 0.766 |
| SkinSen | 0.896 |
| Carcinogencity | 0.827 |
| EI | 0.074 |
| Respiratory | 0.973 |
| NR-Aromatase | 0.629 |
| Antiviral | Yes |
| Prediction | 0.728873 |